Hjem › Leiomyosarkom › Illinois
Leiomyosarkom kliniske forsøg i Illinois
4 studier for Leiomyosarkom søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Rush University Medical Center, Chicago
- University of Illinois at Chicago MBCCOP, Chicago
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT04031677Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- University of Chicago Comprehensive Cancer Center, Chicago
- UC Comprehensive Cancer Center at Silver Cross, New Lenox
- University of Chicago Medicine-Orland Park, Orland Park
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT05711615NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Lurie Children's Hospital of Chicago, Chicago
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. aug. 2026 · NCT06239272XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
- Northwestern University, Chicago
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. jun. 2026 · NCT06571734Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.